Form D · Other Health Care
SpringWorks Therapeutics, LLC
Baltimore, MD · CIK 0001716049
Offering snapshot reported Sep 1, 2017 · SEC filing
- Reported sold
- $12.8M Offering amount: $103M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 18, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 1, 2017 | Initial | $12,815,535 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-293982
Source: Form D, filed Sep 1, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carl Gordon | Director |
| Peter Keen | Director |
| Freda Lewis Hall, M.D. | Director |
| Daniel Lynch | Director, Executive |
| Deval Patrick | Director |
| Jeff Schwartz | Director |
| Stephen Squinto | Director |
| Lara Sullivan, M.D. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Asher Rubin, Hogan Lovells Us Llp 100 International Dr., Suite 2000
Baltimore, MD, 21202
Baltimore, MD, 21202